Achieve Life Sciences ACHV Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate at other companies

Norwood FinancialNWFL

4.5%0.0pp

CHE

ChemedCHE

0.5%+0.2pp

BeldenBDC

0.2%-0.1pp

RBC BearingsRBC

0%—

Quantum Computing Inc.QUBT

0%—

Capital City Bank GroupCCBG

2.6%-0.4pp

Other financials

Income statement

See full

Net income-$10.2M+20.7%

EPS (diluted)-$0.19+48.6%

Balance sheet

See full

Cash & equivalents$28.1M+116%

Total debt$5.6M+332%

Total equity$10.7M+3.9%

Total assets$33.1M+21.0%

Cash flow

See full

Operating cash flow-$6.9M+37.5%

CapEx$750.0—

Free cash flow-$12.4M—

Valuation

See full

Market cap$585.16M+404%

Enterprise value$562.71M+439%

Returns & leverage

See full

Return on equity-496.1%-906pp

Debt / equity0.5×+0.4×

Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's share based compensation arrangement by share based payment award fair value assumptions expected dividend rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Achieve Life Sciences's share based compensation arrangement by share based payment award fair value assumptions expected dividend rate?: Achieve Life Sciences (ACHV) reported share based compensation arrangement by share based payment award fair value assumptions expected dividend rate of 0% in Q1 2026.
What does share based compensation arrangement by share based payment award fair value assumptions expected dividend rate mean?: The weighted-average dividend yield assumption used in option pricing models to estimate the fair value of equity awards. This metric indicates the expected dividend policy relative to the company's share price over the life of the awards.